PETRAMALA, LUIGI
 Distribuzione geografica
Continente #
NA - Nord America 4.676
EU - Europa 1.451
AS - Asia 541
AF - Africa 49
SA - Sud America 28
OC - Oceania 10
Totale 6.755
Nazione #
US - Stati Uniti d'America 4.594
IT - Italia 724
IN - India 270
SE - Svezia 189
CN - Cina 162
FI - Finlandia 116
SG - Singapore 85
BG - Bulgaria 80
CA - Canada 79
UA - Ucraina 78
DE - Germania 63
GB - Regno Unito 50
AT - Austria 35
IE - Irlanda 31
TG - Togo 29
AR - Argentina 23
BE - Belgio 18
CH - Svizzera 18
FR - Francia 12
RO - Romania 12
NL - Olanda 10
ZA - Sudafrica 10
AU - Australia 9
RU - Federazione Russa 8
KE - Kenya 7
TH - Thailandia 6
AE - Emirati Arabi Uniti 5
MY - Malesia 5
PT - Portogallo 4
VN - Vietnam 3
BR - Brasile 2
DZ - Algeria 2
PH - Filippine 2
VE - Venezuela 2
BZ - Belize 1
CL - Cile 1
ES - Italia 1
ID - Indonesia 1
JM - Giamaica 1
KR - Corea 1
MX - Messico 1
NZ - Nuova Zelanda 1
PL - Polonia 1
RS - Serbia 1
SC - Seychelles 1
TW - Taiwan 1
Totale 6.755
Città #
Fairfield 746
Ashburn 390
Chandler 361
Woodbridge 333
Rome 317
Seattle 317
Houston 268
Cambridge 235
Ann Arbor 224
Wilmington 216
Princeton 127
San Paolo di Civitate 111
Dearborn 107
Plano 91
Lawrence 85
Fremont 83
Sofia 80
Beijing 69
Boston 63
San Diego 62
New York 56
Ottawa 56
Millbury 49
Des Moines 43
Helsinki 32
Dublin 31
Vienna 31
Andover 30
Lomé 29
Singapore 28
Milan 26
Napoli 25
Federal 23
Norwalk 21
Jacksonville 20
Toronto 20
Brussels 16
Zurich 16
Bremen 14
Kanpur 12
Nanjing 12
Washington 12
Boardman 11
Hefei 11
Los Angeles 11
Pune 11
Bühl 10
Falls Church 10
Latina 9
San Mateo 8
Jinan 7
Kunming 7
Nairobi 7
Nanchang 7
Cagliari 6
Phoenix 6
Redwood City 6
Caserta 5
Dubai 5
Guangzhou 5
London 5
Marano Di Napoli 5
Muizenberg 5
Palestrina 5
Pretoria 5
Bari 4
Bewdley 4
Buffalo 4
Coimbatore 4
Fuzhou 4
Hyderabad 4
Laurel 4
Mykolayiv 4
Naples 4
Pescantina 4
Pescara 4
Blackheath 3
Chengdu 3
Chennai 3
Chongqing 3
Groningen 3
Hangzhou 3
Hanoi 3
Hat Yai 3
Indiana 3
Mannheim 3
Melbourne 3
Scuola 3
Shanghai 3
Torino 3
Ancona 2
Annaba 2
Antea 2
Anzio 2
Argenteuil 2
Bergamo 2
Bern 2
Bonndorf 2
Capacho Nuevo 2
Casatenovo 2
Totale 5.160
Nome #
Major adverse cardiovascular events in non-valvular atrial fibrillation with chronic obstructive pulmonary disease: the ARAPACIS study 162
Carotid plaque detection improves the predictve value of CHA2DS2-VASc score in patients with non-valvular atrial fibrilation. the ARAPACIS study 142
Electrical and myocardial remodeling in primary aldosteronism 132
Adrenal pheochromocytoma incidentally discovered in a patient with parkinsonism 120
Gastrointestinal and Retroperitoneal Manifestations of Type 1 Neurofibromatosis 119
A rare case report of hypertrophic cardiomyopathy induced by catecholamine-producing tumor 109
Leptin and adiponectin mRNA expression from the adipose tissue surrounding the adrenal neoplasia 106
A case of acute aortic dissection type b associated with cushing's syndrome 104
Bone mineral metabolism in patients with neurofibromatosis type 1 (von Recklingausen disease) 97
Peri-implant diseases and metabolic syndrome components: a systematic review 97
Oxidative stress in patients affected by primary aldosteronism. 95
Analysis of short-term blood pressure variability in pheochromocytoma/paraganglioma patients 94
Ambulatory blood pressure monitoring-derived short-term blood pressure variability in primary hyperparathyroidism 92
Magnetic resonance imaging 3t and total fibrotic volume in autosomal dominant polycystic kidney disease 89
Clinical benefits of unilateral adrenalectomy in patients with subclinical hypercortisolism due to adrenal incidentaloma. Results from a single center 88
Enhanced soluble serum CD40L and serum P-selectin levels in primary aldosteronism 87
Subclinical atherosclerosis due to increase of plasma aldosterone concentrations in essential hypertensive individuals 86
Primary aldosteronism in a patient who exhibited heart failure. 85
Ambulatory blood pressure monitoring in secondary arterial hypertension due to adrenal diseases. 84
Coincidence of Neurofibromatosis Type 1 and Multiple Endocrine Neoplasia Type 2 83
Ambulatory monitoring of blood pressure (AMBP) in patients with primary hyperparathyroidism 82
Neurofibromatosis type 1 with adrenal pheochromocytoma and renal artery stenosis: an uncommon entity of arterial hypertension 82
Arterial hypertension, metabolic syndrome and subclinical cardiovascular organ damage in patients with asymptomatic primary hyperparathyroidism before and after parathyroidectomy: Preliminary results 81
Primary aldosteronism with concurrent primary hyperparathyroidism in a patient with arrhythmic disorders. 81
An unusual association of cerebral meningioma, parathyroid adenoma and thyroid papillary carcinoma 80
Adipokines and cardiometabolic profile in primary hyperaldosteronism 80
Acute hyperinsulinemia is associated with increased plasma adrenomedullin concentrations in uncomplicated obesity 79
Hyperaldosteronism and cardiovascular risk in patients with autosomal dominant polycystic kidney disease 79
Renin-angiotensin-aldosterone system in patients with sleep apnoea: prevalence of primary aldosteronism 75
Bone and mineral metabolism in patients with primary aldosteronism 75
Plasma endothelin-1 levels in patients with resistant hypertension. effects of renal sympathetic denervation 75
Multiple catecholamine-secreting paragangliomas: Diagnosis after hemorrhagic stroke in a young woman 75
Work-related stress and cortisol levels: is there an association? Results of an observational study 74
Silent adrenal pheochromocytoma coexistent with corticomedullary hyperplasia: a case incidentally discovered 74
Comparison of atorvastatin versus fenofibrate in reaching lipid targets and influencing biomarkers of endothelial damage in patients with familial combined hyperlipidemia 73
Response to 'oxidative stress in patients affected by primary aldosteronism' 73
null 71
Nonfunctioning adrenal pheochromocytoma incidentally discovered associated with renal oncocytoma 71
Primary aldosteronism due to adrenocortical adenoma with concurrent ileum carcinoid tumor: case report 70
Brown Fat Expresses Adiponectin in Humans 70
Neurofibromatosis type 1 (NF1) and pheochromocytoma: Prevalence, clinical and cardiovascular aspects 70
Adipokines and cardio-metabolic profile in primary hyperaldosteronism 69
Adrenomedullin plasma concentrations in patients with retinitis pigmentosa 69
Endothelin-1 plasma concentrations in patients with retinitis pigmentosa 68
HYPERALDOSTERONISM AND CARDIOVASCULAR RISK IN PATIENTS WITH AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE 67
High plasma levels of human chromogranin A and adrenomedullin in patients with pheochromocytoma 66
Plasma adrenomedullin and endothelin-1 concentration during low-dose dobutamine infusion: Relationship between pulmonary uptake and pulmonary vascular pressure/flow characteristics 66
Role of Growth Factors on Human Parathyroid Adenoma Cell Proliferation 64
Autoimmune diseases in patients with Cushing’s syndrome after resolution of hypercortisolism: Case reports and literature review 63
A sleep apnoea questionnaire predicts organ damage in hypertensive patients 63
Intracoronary adiponectin levels rapidly and significantly increase after coronary revascularization 62
Relation of adiponectin, visfatin and bone mineral density in patients with metabolic syndrome. 61
Epicardial fat thickness and left ventricular mass in subjects with adrenal incidentaloma 61
Cardiovascular and metabolic risk factors in patients with subclinical Cushing 61
Epicardial Adipose Tissue and Intracoronary Adrenomedullin Levels in Coronary Artery Disease 60
Epicardial Adipose Tissue Adiponectin Expression is Related to Intracoronary Adiponectin Levels 60
α-lipoic acid in patients with autosomal dominant polycystic kidney disease 60
Von Hippel Lindau Disease with Colon Adenocarcinoma, Renal Cell Carcinoma and Adrenal Pheochromocytoma 59
A giant hemorragic adrenal pseudocyst: contrast-enhanced examination (CEUS) and computed tomography (CT) features 58
Epicardial fat thickness in patients with autosomal dominant polycystic kidney disease 58
Time to hospitalisation, CT pulmonary involvement and in-hospital death in COVID-19 patients in an Emergency Medicine Unit 58
Feocromocitoma e NF1 57
Pigmented 'black' cardiac paraganglioma in a patient with a novel germ-line SDHD mutation 56
IL TRATTAMENTO DELLE DISLIPIDEMIE NELLA PREVENZIONE PRIMARIA DELLE MALATTIE CARDIOVASCOLARI: LE INDICAZIONI PER LA PRATICA CLINICA 55
Pseudocystic pheochromocytoma: An incidental finding and a rare entity 54
Clinical indications for anti-COVID-19 antibodies use 52
The prevalence of resistant arterial hypertension and secondary causes in a cohort of hypertensive patients: a single center experience 51
Hypokalemic rhabdomyolysis: a rare manifestation of primary aldosteronism 50
Comparisons of skin microvascular changes in patients with primary aldosteronism and essential hypertension 50
Evaluation of intra-renal stiffness in patients with primary aldosteronism 49
Late recurrence after surgical resection of a pancreatic tumor in von Hippel-Lindau disease 47
Outcomes of adrenal-sparing surgery or total adrenalectomy in phaeochromocytoma associated with multiple endocrine neoplasia type 2: an international retrospective population-based study 47
Vitreous and plasma changes of endothelin-1, adrenomedullin and vascular endothelium growth factor in patients with proliferative diabetic retinopathy 47
Cushing's Syndrome patient who exhibited congestive heart failure 46
Resistant arterial hypertension in a patient with adrenal incidentaloma multiple steno-obstructive vascular lesions and antiphospholipid syndrome 45
Parathyroidectomy erase increased myocardial electrical vulnerability in patients with primary hyperparathyroidism 44
Cardiomyopathies and adrenal diseases 44
Adrenal pheochromocytoma and jejunal neurofibroma in type 1 neurofibromatosis: report of a case. 42
null 42
Venous endotelin-1 (ET-1) and brain natriuretic peptide (BNP) plasma levels during 6-month bosentan treatment for pulmonary arterial hypertension 41
Atrial fibrillation as presenting sign of primary aldosteronism. Results of the prospective appraisal on the prevalence of primary aldosteronism in hypertensive (papphy) study 41
Cushing syndrome cardiomyopathy. clinicopathologic impact of cortisol normalization 41
Adrenal pheochromocytoma associated with "tako-tsubo" syndrome]. 41
Circulanting leptin and adinopectin levels in patients with primary hiperparathyroidism 40
Surgical treatment of extra-adrenal abdominal paragangliomas 38
Aldosterone-induced oxidative stress: a potential mechanism of aldosterone autonomy in primary aldosteronism 36
Thrombotic aspects of SARS-CoV-2 infection: indications for treatment 36
Plasma adrenomedullin concentrations in patients with renovascular or malignant hypertension. 36
Natural activators of autophagy reduce oxidative stress and muscle injury biomarkers in endurance athletes. a pilot study 35
EPICARDIAL EXPRESSION OF ADRENOMEDULLIN, A PEPTIDE WITH CARDIOVASCULAR PROTECTIVE EFFECTS, IN PATIENTS WITH AND WITHOUT CORONARY ARTERY DISEASE 35
Stress-moderating effects of positive emotions: Exposure to humorous movies during hemodialytic sessions decreases blood levels of stress hormones 35
Surgical management of extra-adrenal abdominal paragangliomas. Report of three cases and review of the literature 35
The 2020 italian society of arterial hypertension (siia) practical guidelines for the management of primary aldosteronism 35
incidenza del feocromocitoma e di patologie endocrine in gruppo di pazienti affetti da neurofibromatosi di tipo 1 33
Surgical management of adrenocortical carcinoma: current highlights 33
null 32
Papilledema in patient with primary aldosteronism: an unusual case report 32
High prevalence of thyroid disfunction in primary hyperaldosteronism 30
The use of parenteral clodronate in elderly women with postmenopausal osteoporosis: compliance, effects on bone mineral density and on bone turnover 30
Analysis of the miRNA expression from the adipose tissue surrounding the adrenal neoplasia 27
Totale 6.534
Categoria #
all - tutte 18.028
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 18.028


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019392 0 0 0 0 0 0 0 0 0 0 216 176
2019/20201.694 171 35 38 89 143 246 282 195 198 160 73 64
2020/2021794 103 52 37 47 23 113 15 74 95 170 41 24
2021/20221.285 29 77 99 38 153 41 21 116 114 107 264 226
2022/20231.407 244 314 79 139 137 149 20 97 141 16 43 28
2023/2024834 42 95 49 59 97 205 41 102 20 117 7 0
Totale 7.140